 |
 |

Altered Expression of Neurotransmitter Receptors and Neuromediators in Vernal Keratoconjunctivitis
Laura Motterle, MD;
Yolanda Diebold, PhD;
Amalia Enríquez de Salamanca, PhD;
Victoria Saez, BS;
Carmen Garcia-Vazquez, BS;
Michael E. Stern, PhD;
Margarita Calonge, MD;
Andrea Leonardi, MD
Arch Ophthalmol. 2006;124:462-468.
Background There is growing evidence that autonomic innervation is involved in the pathogenesis of mucus hypersecretion, goblet cell hyperplasia, and conjunctival hyperreactivity.
Objective To determine the expression of neurotransmitters and neurotransmitter receptors in vernal keratoconjunctivitis (VKC) tissues to evaluate whether neurogenic inflammation plays a role in this ocular atopic-related disorder.
Methods Biopsy specimens of upper tarsal conjunctiva from 8 VKC patients with active inflammation and from 4 healthy subjects were processed for immunohistochemistry using anti-M1, anti-M2, and anti-M3 muscarinic receptors; 1-adrenergic receptor; vasoactive intestinal peptide; nerve growth factor; and protein gene product 9.5, a marker of nerve fibers.
Results In the conjunctival epithelium of VKC patients, M1muscarinic receptor, nerve growth factor, and protein gene product 9.5 expression were decreased, whereas M2 and M3 muscarinic receptors and 1-adrenergic receptor were irregularly distributed, compared with control subjects. Neurotransmitter receptors and vasoactive intestinal peptide expression were increased in the substantia proprialocalized infiltrate of VKC compared with healthy tissue. Nerve growth factor and protein gene product 9.5 staining was also enhanced in the conjunctival stroma of VKC vs healthy conjunctiva.
Conclusions The inflamed conjunctiva of VKC patients demonstrated an obvious alteration in muscarinic and 1-adrenergic receptor, vasoactive intestinal peptide, protein gene product 9.5, and nerve growth factor expression. These results substantiate the involvement of an autonomic dysfunction in the pathogenesis of VKC.
Author Affiliations: Department of Neuroscience, Ophthalmology Unit, University of Padova, Padova, Italy (Drs Motterle and Leonardi); Instituto Universitario de Oftalmobiologia Aplicada, University of Valladolid, Valladolid, Spain (Drs Diebold, Enríquez de Salamanca, and Calonge and Mss Saez and Garcia-Vazquez); and Allergan Inc, Irvine, Calif (Dr Stern).
THIS ARTICLE HAS BEEN CITED BY OTHER ARTICLES
Expression and Function of Muscarinic Receptor Subtypes on Human Cornea and Conjunctiva
Liu et al.
IOVS 2007;48:2987-2996.
ABSTRACT
| FULL TEXT
|